Home › Sickle Cell Disease › Mississippi
Sickle Cell Disease clinical trials in Mississippi
5 studies for Sickle Cell Disease are looking for participants at sites in Mississippi.
Cities in Mississippi
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
- Southern Specialty Clinic, Flowood
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07656415A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Southern Specialty Research, Flowood
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 28, 2026 · NCT06439082A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Southern Specialty Research, Flowood
RecruitingPhase 2/3
Ages 12 and older · All sexes · Updated Aug 18, 2026 · NCT05431088Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Southern Specialty Research, Flowood
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Southern Specialty Research- Site Number : 8400059, Flowood
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Jul 29, 2026 · NCT06975865From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.